Grants from Karen Elise Jensen Fonden

8 June 2020 Karen Dybkær and Marianne Tang Severinsen have each received a grant from Karen Elise Jensen. Karen Dybkær has received DKK 3.000.000 from Karen Elise Jensen Fonden for the project “Behandlingsresistens i maligne B-celle blodsygdomme – kombination af CRISPR-baseret Read more

Researchers from our Research Section win competition

19 June 2020 Research teams from all over the world have competed to see who are the best at predicting the outcome of cancer treatments, and researchers from our Haematological Research Section have taken a prestigious victory. Read more here:  

Issa Ismail Issa

Scientific assistant Education: M.Sc. (Biomedicine) Work area: Experimental investigation of chemotherapy resistance in DLBCL using techniques such as cloning, CRISPR/Cas9 knockout, dose-response assays, PCR, flow cytometry E-mail: i.issa@rn.dk Phone: +45 97 66 08 64 www.haematologi.rn.dk   Aalborg University Hospital Department Read more

Grant from Kræftens Bekæmpelse

12 June 2020 Karen Dybkær has received DKK 2.325.000from Kræftens Bekæmpelse for the project “Molekylære kendetegn for patienter med diffus storcellet B-celle lymfom, som har effektivt respons på behandling med bortezomib”. Read more here  

Joachim Bæch

PhD student Education: MD, Aarhus University, 2019 Work area: Epidemiological research in toxicities and long-term outcomes following lymphoma treatment. E-mail: j.baech@rn.dk Phone: +45 97 66 08 64 Fax: +45 97 66 63 23 www.haematologi.rn.dk   Aalborg University Hospital Department of Haematology Read more

Linnéa Schmidt

Postdoc Education: Master of Pharmaceutical Science in Pharmacy Work area: E-mail: linnea.schmidt@rn.dk Phone: +45 97 66 38 73 Fax: +45 97 66 63 23 www.haematologi.rn.dk   Aalborg University Hospital Department of Haematology Science and Innovation Center Sdr. Skovvej 15 DK-9000 Aalborg Read more

Grant from Harboe Fonden

13 February 2020 Linnéa Schmidt has received 50,000 DKK from the Harboe Foundation for the project ”Exploring actionable stratifications of B-cell cancer patients using CRISPR/Cas9 genetic screening”. The study aims at identifying treatment resistance genes in the B-cell malignancy diffuse Read more